Calixarene Modification Strategy for Efficient Intracellular Protein Delivery
Macromolecular Bioscience · 2025
DOI: 10.1002/mabi.202400626 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, 2025. Verfasst von Yong Ke und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Imaging, Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University, Tianjin, 300203, China. Hauptthemen laut MEDLINE: Calixarenes, Drug Delivery Systems, Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Tianjin Municipal Science and Technology Bureau, Animal Ethics Committee of Tianjin Medical University.
Abstract (Originalsprache)
Efficient intracellular protein delivery is of great importance for the development of protein‐based therapy and modern biotechnologies. However, the hydrophilic and macromolecular nature of proteins greatly hinders their ability to cross cell membranes. Herein, a calixarene modification strategy for the intracellular delivery of protein drugs is developed. The decoration of sulfonate azocalix[4]arene (SAC4A) on proteins results in a nano‐multivalent effect between Protein‐S and amino acids on the cell surface, leading to efficient intracellular delivery of the protein via the clathrin‐mediated endocytic pathway. By using SAC4A as a novel ligand, this calixarene modification strategy efficiently delivers 7 proteins, bovine serum albumin (BSA), trypsin (TRY), horseradish peroxidase (HRP), α‐chymotrypsin (α‐Chyt), lysozyme (LYZ), cytochrome C (Cyt C) and ribonuclease A (RNase A), into cells and significantly enhances the cytotoxicity of Cyt C and RNase A. Moreover, SAC4A‐modified Cyt C demonstrates markedly enhanced antitumor efficacy in 4T1‐bearing mice without notable side effects. Considering that these proteins are varied in molecular weight and isoelectric point, this calixarene modification strategy provides a platform technology for intracellular protein delivery and the development of protein drugs targeting intracellular pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Imaging, Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University, Tianjin, 300203, China.
- Department of Plastic Surgery, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, 300041, China.
- College of Chemistry, Key Laboratory of Functional Polymer Materials (Ministry of Education), Nankai University, Tianjin, 300071, China.
ORCID-Profile: Yang Liu
Förderung
- National Natural Science Foundation of China
- Tianjin Municipal Science and Technology Bureau
- Animal Ethics Committee of Tianjin Medical University
Zitieren
APA
Ke, Y., Li, S., Shao, Y., Li, Q., Wang, Y., Zhang, Z., & Liu, Y. (2025). Calixarene Modification Strategy for Efficient Intracellular Protein Delivery. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202400626
Vancouver
Ke Y, Li S, Shao Y, Li Q, Wang Y, Zhang Z, et al. Calixarene Modification Strategy for Efficient Intracellular Protein Delivery. Macromolecular Bioscience. 2025. doi:10.1002/mabi.202400626
BibTeX
@article{Ke2025,
author = {Ke, Yong and Li, Shuangxiu and Shao, Yan and Li, Qiushi and Wang, Ying and Zhang, Zhanzhan and Liu, Yang},
title = {Calixarene Modification Strategy for Efficient Intracellular Protein Delivery},
journal = {Macromolecular Bioscience},
year = {2025},
doi = {10.1002/mabi.202400626}
}
EUVIMED